Cargando…

Impact of Shocks on Mortality in Patients with Ischemic or Dilated Cardiomyopathy and Defibrillators Implanted for Primary Prevention

BACKGROUND: Emerging interest is seen in the paradox of defibrillator shocks for ventricular tachyarrhythmia and increased mortality risk. Particularly in patients with dilated cardiomyopathy (DCM), the prognostic importance of shocks is unclear. The purpose of this study was to compare the outcome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Streitner, Florian, Herrmann, Thomas, Kuschyk, Juergen, Lang, Siegfried, Doesch, Christina, Papavassiliu, Theano, Streitner, Ines, Veltmann, Christian, Haghi, Dariusch, Borggrefe, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651165/ https://www.ncbi.nlm.nih.gov/pubmed/23675514 http://dx.doi.org/10.1371/journal.pone.0063911

Ejemplares similares

Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy
por: Fluechter, Stephan, et al.
Publicado: (2010)

Right Ventricular Function Quantification in Takotsubo Cardiomyopathy Using Two-Dimensional Strain Echocardiography
por: Heggemann, Felix, et al.
Publicado: (2014)

The Relationship between the Severity of Coronary Artery Disease and Epicardial Adipose Tissue Depends on The Left Ventricular Function
por: Doesch, Christina, et al.
Publicado: (2012)

CMR-derived TAPSE measurement: a semi-quantitative method of right ventricular function assessment in patients with hypertrophic cardiomyopathy
por: Doesch, C., et al.
Publicado: (2014)

Capsule Endoscopy in a Patient with an Implanted CCM System and an Implantable Defibrillator
por: Streitner, Florian, et al.
Publicado: (2011)

Epicardial adipose tissue in patients with heart failure
por: Doesch, Christina, et al.
Publicado: (2010)

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Papavassiliu, Theano, et al.
Publicado: (2009)

Myocardial Scar Detected by Cardiovascular Magnetic Resonance in a Competitive Bodybuilder With Longstanding Abuse of Anabolic Steroids
por: Baumann, Stefan, et al.
Publicado: (2014)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
por: Doesch, Christina, et al.
Publicado: (2017)

Cellular Imaging of Human Atherosclerotic Lesions by Intravascular Electric Impedance Spectroscopy
por: Streitner, Ines, et al.
Publicado: (2012)

Prevalence, Clinical Characteristics, and Predictors of Patients with Thromboembolic Events in Takotsubo Cardiomyopathy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2016)

Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long‐Term Follow‐Up
por: Rudic, Boris, et al.
Publicado: (2017)

Right Ventricular and Right Atrial Involvement Can Predict Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy?
por: Doesch, Christina, et al.
Publicado: (2016)

Clinical and echocardiographic analysis of patients suffering from recurrent takotsubo cardiomyopathy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2016)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Impact of implantable cardioverter defibrillator on survival in patients with non‐ischemic dilated cardiomyopathy
por: Kataoka, Naoya, et al.
Publicado: (2023)

Prediction of cardiac events with non‐contrast magnetic resonance feature tracking in patients with ischaemic cardiomyopathy
por: Overhoff, Daniel, et al.
Publicado: (2021)

Selvester score predicts implantable cardioverter defibrillator shocks in patients with non‐ischemic cardiomyopathy
por: Arısoy, Fazıl, et al.
Publicado: (2021)

Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy
por: Abumayyaleh, Mohammad, et al.
Publicado: (2021)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting
por: Röger, Susanne, et al.
Publicado: (2018)

Factors associated with implantable cardioverter-defibrillator shocks in patients suffering from non-ischemic cardiomyopathy
por: Rezaee, Mahmood, et al.
Publicado: (2022)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Global transcript profiling of transgenic plants constitutively overexpressing the RNA-binding protein AtGRP7
por: Streitner, Corinna, et al.
Publicado: (2010)

Defibrillator and non-ischaemic dilated cardiomyopathy: a never ending story
por: Notaristefano, Francesco, et al.
Publicado: (2019)

Septal myocardial scar burden predicts the response to cardiac contractility modulation in patients with heart failure
por: Ansari, Uzair, et al.
Publicado: (2022)

Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy
por: Salehi Omran, Hossein, et al.
Publicado: (2023)

Risk stratification in families with history of idiopathic ventricular fibrillation
por: Kruska, Mathieu, et al.
Publicado: (2020)

Rapid functional cardiac imaging after gadolinium injection: Evaluation of a highly accelerated sequence with sparse data sampling and iterative reconstruction
por: Budjan, Johannes, et al.
Publicado: (2016)

Predictors of Implantable Cardioverter-Defibrillator Use in Patients with Ischemic Cardiomyopathy
por: Kelly, Ryan, et al.
Publicado: (2010)

The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up
por: Rosenkaimer, Stephanie L., et al.
Publicado: (2020)

The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy
por: Spänig, Sabine, et al.
Publicado: (2019)

Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy
por: Haas, Jan, et al.
Publicado: (2021)

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
por: Gao, Wei, et al.
Publicado: (2023)

Role of the Wearable Defibrillator in Newly Diagnosed Heart Failure
por: Duncker, David, et al.
Publicado: (2018)

Defibrillators for prevention from sudden cardiac death: is it that easy?
por: Duncker, David, et al.
Publicado: (2020)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Reciprocal regulation of glycine-rich RNA-binding proteins via an interlocked feedback loop coupling alternative splicing to nonsense-mediated decay in Arabidopsis
por: Schöning, Jan C., et al.
Publicado: (2008)

Follow-up of implantable cardioverter-defibrillator therapy: comparison of coronary artery disease and dilated cardiomyopathy
por: Verhagen, M. P., et al.
Publicado: (2014)

Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy without defibrillator
por: Samy, Mohammed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_opt62o7n48pffgodvqjd9a3vdi